Results 111 to 120 of about 3,535 (191)

Long-term efficacy and safety of solifenacin, mirabegron, and their combination for overactive bladder: a systematic review. [PDF]

Front Pharmacol
Yang L, Zhao H, Xiao S, Ye Z.
europepmc   +1 more source

Clinical CYP2D6-Mediated Pharmacokinetic Drug-Drug Interactions of DA-8010 with Paroxetine or Mirabegron in Healthy Korean Participants. [PDF]

Drug Des Devel Ther
Ryu H, Cho JY, Lee DY, Lee S.
europepmc   +1 more source

Urine Epidermal Growth Factor/Creatinine Ratio in Female Patients with Overactive Bladder and Recurrent Lower Urinary Tract Infection. [PDF]

Gynecol Minim Invasive Ther
Yang TH, Chen CC, Chou YM, Liu JM, Huang KH, Chuang FC.   +5 more
europepmc   +1 more source

Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis. [PDF]

Eur Urol Open Sci
Chen SH, Chen CY, Hadi FA.
europepmc   +1 more source

Correction: Efficacy and safety of mirabegron versus solifenacin in the treatment of overactive bladder in children: a systematic review and meta-analysis. [PDF]

BMC Urol
Shaheen M, Ali OM, Draz AA, Barakat AK, Elghattas A, Elbaz T, Walid I, Tarboush T, Elsayed A, Mahmoud T, Elkhateeb EM, Nofal AA, Samaan E.   +12 more
europepmc   +1 more source

Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review. [PDF]

Adv Ther
Gill BC, Rosenberg MT, Kaplan SA, Lerner LB.   +3 more
europepmc   +1 more source

Blood pressure increases and other safety and medication compliance in overactive bladder patients treated with Selebeta^® PR tablets: A noninterventional, multicenter, retrospective observational study. [PDF]

Investig Clin Urol
Lee JH, Kim A, Shim JS, Ko KJ.
europepmc   +1 more source

Comparison of the efficacy of alfuzosin and mirabegron on symptoms associated with Double-J stent placement after retrograde intrarenal surgery. [PDF]

Urol Ann
Öztürk M, Taskir F, Erturhan S, Zeytun O, Bayrak O, Seckiner I.   +5 more
europepmc   +1 more source

Mirabegron in patients with age-related macular degeneration treated for overactive bladder: a study protocol for a prospective observational non-randomized trial. [PDF]

Front Med (Lausanne)
Ambrosio L, Cammalleri M, Panariello S, Califano G, Scala A, Improta G, Pisani A, Rejdak R, Ostrowski I, Filippi L, Bagnoli P, Dal Monte M, Toro MD.   +12 more
europepmc   +1 more source

Side effects of medical therapy for non-neurogenic lower urinary tract symptoms in children: a UK-based single centre retrospective case-note review. [PDF]

BMJ Paediatr Open
Wong J, Corbett HJ.
europepmc   +1 more source